Bradley Herring Sells 1,533 Shares of Enfusion, Inc. (NYSE:ENFN) Stock

Enfusion, Inc. (NYSE:ENFN) CFO Bradley Herring sold 1,533 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $11.48, for a total transaction of $17,598.84. Following the sale, the chief financial officer now owns 329,334 shares in the company, valued at $3,780,754.32. The trade was a 0.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Bradley Herring also recently made the following trade(s):

• On Tuesday, January 7th, Bradley Herring sold 4,134 shares of Enfusion stock. The shares were sold at an average price of $10.13, for a total transaction of $41,877.42.
• On Friday, December 20th, Bradley Herring sold 24,443 shares of Enfusion stock. The shares were sold at an average price of $10.61, for a total transaction of $259,340.23.

Enfusion Stock Performance

ENFN opened at $11.29 on Friday. The stock has a market capitalization of $1.45 billion, a price-to-earnings ratio of 282.20, a PEG ratio of 1.85 and a beta of 0.95. The company has a fifty day moving average of $10.96 and a 200 day moving average of $9.86. Enfusion, Inc. has a fifty-two week low of $7.83 and a fifty-two week high of $11.80.

Enfusion (NYSE:ENFN) last issued its quarterly earnings data on Monday, March 3rd. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). Enfusion had a return on equity of 6.67% and a net margin of 1.70%. The business had revenue of $52.94 million during the quarter, compared to analysts’ expectations of $53.98 million. On average, equities research analysts forecast that Enfusion, Inc. will post 0.06 earnings per share for the current year.

Hedge Funds Weigh In On Enfusion

Institutional investors and hedge funds have recently made changes to their positions in the business. KLP Kapitalforvaltning AS purchased a new position in shares of Enfusion in the 4th quarter worth $75,000. Millennium Management LLC purchased a new position in shares of Enfusion in the 4th quarter worth $114,000. Harbor Capital Advisors Inc. grew its stake in shares of Enfusion by 12.4% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock worth $113,000 after buying an additional 1,315 shares in the last quarter. Belvedere Trading LLC purchased a new position in shares of Enfusion in the 3rd quarter worth $114,000. Finally, Dark Forest Capital Management LP purchased a new position in shares of Enfusion in the 4th quarter worth $128,000. 81.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ENFN. Stifel Nicolaus raised their price objective on shares of Enfusion from $11.00 to $13.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. William Blair reaffirmed a “market perform” rating on shares of Enfusion in a research note on Monday, January 13th. Finally, Piper Sandler raised their target price on shares of Enfusion from $10.00 to $11.50 and gave the company a “neutral” rating in a research note on Monday, December 23rd. One analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $11.13.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.